- Home
- / KHB
KHB
Stock Price
¥6.5
2024-10-29
Market Capitalization
¥3.3 B
2024-10-29
Revenue
¥1.6 B
FY, 2025
KHB Summary
Company Summary
- Overview
- KHB (Kehua Bio-Engineering) is a healthcare company that provides medical diagnostic products. It offers automatic chemiluminescence immunoassay analyzers, modular biochemical analysis systems, antibody and antigen detection kits, etc. The company provides biochemical, molecular, and immunologic diagnosis solutions.
- Type
- Public
- Status
- Active
- Founded
- 1981
- Website
- https://www.skhb.com/cn/
- Cybersecurity rating
Table of Contents
KHB Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥393.9M
- Gross profit (Q1, 2026)
- ¥144.3M
- Net income (Q1, 2026)
- (¥43.4M)
- Cash (Q1, 2026)
- ¥803.9M
- EBIT (Q1, 2026)
- (¥35.0M)
- Enterprise value
- $3.2B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026